Mark B. Blick

3.5k citations
61 papers · 3.2k · h-index 29

Impact in

  • Hematology top 2%
    • Chronic Myeloid Leukemia Treatments
    • Multiple Myeloma Research and Treatments
  • Oncology top 5%
    • HER2/EGFR in Cancer Research
    • Drug Transport and Resistance Mechanisms

Papers in

Mark B. Blick

61 papers receiving 3.0k citations

Peers

Mark B. Blick
Comparison fields: 5 of 68
  • Hematology 599
  • Oncology 415
  • Cancer Research 173
  • Reproductive Medicine 125
  • Pathology and Forensic Medicine 195
Replace Norihiko Kawamata with:
Norihiko Kawamata Japan
R.S.K. Chaganti United States
Tracy Chaplin United Kingdom
Catherine Lofton–Day United States
Norihisa Matsuyoshi Japan
V.V.V.S. Murty United States
Yoshihiro Hatta Japan
S.C. Jhanwar United States
Rose Ann Padua United Kingdom
Fernando Ravagnani Italy
Mark B. Blick relative to Norihiko Kawamata Japan Norihiko Kawamata's profile →
Citations per field
00.5×1.6×
Norihiko Kawamata · 1×
Citations per year

Countries citing papers authored by Mark B. Blick

Since Specialization
Citations

This map shows the geographic impact of Mark B. Blick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark B. Blick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark B. Blick more than expected).

Fields of papers citing papers by Mark B. Blick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark B. Blick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark B. Blick. The network helps show where Mark B. Blick may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark B. Blick, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark B. Blick Line = papers co-authored together Mark B. Blick links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase I study of recombinant tumor necrosis factor in cancer patients.
1987390
2 1987249
3 1988193
4
Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas.
1990180
5 1989165
6 1991149
7
c-erbB-2 amplification in node-negative human breast cancer.
1989111
8 1990110
9
Amplified and overexpressed epidermal growth factor receptor gene in uncultured primary human breast carcinoma.
1988107
10 198899
11 198893
12 198791
13 198890
14
Analysis of the epidermal growth factor receptor gene in fresh human head and neck tumors.
198779
15 198578
16 198475
17 198772
18 198758
19
Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
198852
20
Allele loss at the c-Ha-ras1 locus in human ovarian cancer.
198950

About Mark B. Blick

Mark B. Blick is a scholar working on Hematology, Pathology and Forensic Medicine, Oncology, Reproductive Medicine and Cancer Research, having authored 61 papers that have together received 3.2k indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (14 papers), Lymphoma Diagnosis and Treatment (6 papers), HER2/EGFR in Cancer Research (6 papers), Genetic factors in colorectal cancer (3 papers), Cancer therapeutics and mechanisms (2 papers), Acute Myeloid Leukemia Research (2 papers), Ovarian cancer diagnosis and treatment (2 papers) and Breast Cancer Treatment Studies (2 papers). The work is most often cited by research in Hematology (599 citations), Oncology (415 citations), Cancer Research (173 citations), Reproductive Medicine (125 citations) and Pathology and Forensic Medicine (195 citations). Mark B. Blick has collaborated with scholars based in United States, Israel and Canada. Frequent co-authors include Jordan U. Gutterman, Michael G. Rosenblum, Stephen A. Sherwin, Razelle Kurzrock, Moshe Talpaz, Gabriel N. Hortobágyi, Jae Yoon Ro, Miloslav Beran, David M. Wildrick and Mordechai Shtalrid. Their work appears in journals such as Blood, Cancer, Hematological Oncology, Leukemia Research and Biochemical and Biophysical Research Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact